Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Joaquim Bosch-BarreraJorge Iriarte

Abstract

Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer. We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.

References

Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James J Lee, Sandra M Swain
Jul 4, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edith A PerezGabriel N Hortobagyi
Mar 11, 2008·Critical Reviews in Oncology/hematology·Andreas A ArgyriouHaralabos P Kalofonos
Jul 23, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S GoelS Mani
Jul 24, 2008·The Annals of Pharmacotherapy·Shriya Bhushan, Christine M Walko
Oct 9, 2008·Current Opinion in Oncology·Mary Cianfrocca

❮ Previous
Next ❯

Citations

Jan 8, 2011·Expert Opinion on Drug Safety·David BalayssacNicolas Authier
May 31, 2011·Journal of Pain and Symptom Management·Andreas A ArgyriouHaralabos P Kalofonos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Axonal Neuropathies

Axonal Neuropathy refers to disease or dysfunction of nerves caused as a result of damage or degeneration of axons. Here is the latest research.